Not yet recruitingPhase 4NCT07476339

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CAN Community Health
Principal Investigator
Jessica Altamirano, MD, LMFT
CAN Community Health
Intervention
Bictegravir, emtricitabine, and tenofovir alafenamide(drug)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2026

Study locations (10)

Collaborators

Gilead Sciences · Midway Specialty Care Center · Costello Medical Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07476339 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials